Pancytopenia and stomatitis induced by low-dose methotrexate use
Rheumatoid arthritis (RA) is the most common systemic, autoimmune, and chronic inflammatory disease causing symmetrical arthritis in joints. To prevent its progression, disease-modifying drugs are used. Among these, methotrexate (MTX) is the first choice drug. MTX is an agent which blocks deoxyribon...
Main Authors: | Hüseyin Yildiz, Ibrahim Tayci, Özge Yildiz, Mustafa Volkan Demir |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | CHRISMED Journal of Health and Research |
Subjects: | |
Online Access: | http://www.cjhr.org/article.asp?issn=2348-3334;year=2017;volume=4;issue=1;spage=52;epage=54;aulast=Yildiz |
Similar Items
-
Methotrexate-induced nonhealing cutaneous ulcers in a nonpsoriatic patient without pancytopenia
by: Venkatesh Krishnamurthy Tekur
Published: (2016-01-01) -
Methotrexate-induced cutaneous ulceration without pancytopenia in a patient treated for inflammatory arthritis
by: Ronald Berna, BS, et al.
Published: (2021-07-01) -
A Patient with Rheumatoid Arthritis under Methotrexate and Etanercept Treatment Presenting with Fever and Pancytopenia: An Unexpected Guest
by: Dimitrios Patoulias, et al.
Published: (2021-01-01) -
Pancytopenia following rituximab therapy in a patient with rheumatoid arthritis: Could filgrastim be a temporary solution?
by: Robin George Manappallil
Published: (2016-08-01) -
Relationship between methotrexate dose and clinical efficacy for treatment of rheumatoid arthritis
by: HE Longquan, et al.
Published: (2020-09-01)